The Digital Data Protection rules have hits and misses
Mint Bangalore|January 06, 2025
Some provisions can set a global example for age-gating but others would overburden data fiduciaries
RAHUL MATTHAN

The draft Digital Personal Data Protection (DPDP) Rules are finally with us and the long wait has for the most part been worth it. There is enough detail in the rules to give businesses the clarity they need, but not so much that compliance becomes cumbersome. That said, there are two areas—data breaches and the obligations of significant data fiduciaries—where I believe the government has exceeded its brief. It has in the process greatly increased the burden on data fiduciaries.

Rule 6 provides a definition of the term "reasonable security measures" mentioned in Section 8 of the DPDP Act. As a result, data fiduciaries now have to put in place at least seven distinct types of measures to safeguard against data breaches. While I have no argument with as many measures as are necessary to protect data, why all data fiduciaries must implement these seven measures is beyond me. Section 8 only required data fiduciaries to take reasonable security safeguards. The government should have left well alone and allowed individual data fiduciaries to determine what is reasonable in their own context. By insisting that everyone has to put in place all these measures, it is disproportionately increasing the burden on small data fiduciaries.

Denne historien er fra January 06, 2025-utgaven av Mint Bangalore.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra January 06, 2025-utgaven av Mint Bangalore.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA MINT BANGALORESe alt
Mint Bangalore

Nvidia Shows New Chips, Inks Toyota Deal for Robotic Cars

Shares of Toyota, Nvidia's suppliers rise on optimism about the AI chip maker's prospects

time-read
3 mins  |
January 08, 2025
Mint Bangalore

DIAL drops plea over Hindon ops expansion

Delhi International Airport Ltd (DIAL) on Tuesday withdrew its legal challenge against the Centre's decision to allow the Airports Authority of India (AAI) to operate scheduled commercial flights from the Indian Air Force Station in Hindon, Ghaziabad.

time-read
1 min  |
January 08, 2025
Mint Bangalore

Auto sales rise 9% in 2024 despite headwinds: Fada

Inventory build-up, delayed harvest payments, weak consumer sentiment weighed on demand in Dec

time-read
1 min  |
January 08, 2025
Mint Bangalore

Razorpay Charts Return to India; Eyes Expansion, IPO

Firm is likely to complete its reverse-flip in six months, with an IPO expected in two years

time-read
3 mins  |
January 08, 2025
Mint Bangalore

Bank profits set to moderate in FY26 as bad assets rise

Ind-Ra sharply revised down its FY25 system credit growth estimate to 13-13.5% from 15% earlier

time-read
2 mins  |
January 08, 2025
Mint Bangalore

Lloyds Metals shines on likely gains from acquisition, capex

Lloyds Metals & Energy Ltd's shares have gained about 15% so far in 2025 after the company's quarterly update and announcement of employee stock options (Esops) for its 6,000 workers.

time-read
1 min  |
January 08, 2025
Mint Bangalore

Another tough year for FMCG?

Feeling blue

time-read
2 mins  |
January 08, 2025
Mint Bangalore

Your fancy, new ETF might be a little too fancy

Exchange-traded funds have mostly been great investments, but they are getting too complex for their own good

time-read
4 mins  |
January 08, 2025
Mint Bangalore

Risks to economy escalating in 2025, cautions SBICAPS

Rising household debt, fluctuating FII flows among risks that threaten to amplify economic fragility: Report

time-read
1 min  |
January 08, 2025
Mint Bangalore

Intas Pharma bags another overseas company

Gujarat-based drug-maker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek, and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.

time-read
1 min  |
January 08, 2025